Dr. Shusterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 E 70th St
# Starr
New York, NY 10021Phone+1 646-962-2357Fax+1 646-962-0115
Summary
- Dr. Michael Shusterman is a medical oncologist and Clinical Assistant Professor of Medicine affiliated with the Permutter Cancer Center at NYU Langone Hospital - Long Island and the NYU Long Island School of Medicine in Mineola, NY. His practice is specialized in gastrointestinal cancers. He has research interests in gastrointestinal cancer, medical education, and supportive care studies. He received his medical degree from Albert Einstein College of Medicine. and completed internal medicine residency at Albert Einstein College of Medicine-Montefiore Medical Center. He completed his subspecialty training in hematology and oncology at NewYork Presbyterian-Weill Cornell Medical Center. He speaks English, Russian, and basic Spanish.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2014 - 2017
- Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
- NY State Medical License 2017 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO Annual Meeting Merit Award ASCO Conquer Cancer Foundation, 2020
Clinical Trials
Publications & Presentations
PubMed
- 90 citationsCOVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman, Brandon Swed, Evgeniya Reshetnyak
Journal of Clinical Oncology. 2020-09-28 - 5 citationsTankyrase inhibition sensitizes cells to CDK4 blockadeMiguel Foronda, Yusuke Tarumoto, Emma M Schatoff, Benjamin I. Leach, Bianca J. Diaz
Plos One. 2019-12-31 - 8 citationsTumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.Hussein Alnajar, Hiranmayi Ravichandran, André Figueiredo Rendeiro, Kentaro Ohara, Wael Al Zoughbi
Cold Spring Harbor Molecular Case Studies. 2022-04-01
Press Mentions
- NYU Langone Health in the News—Thursday, May 30, 2024May 30th, 2024
- Blood-Based 'Liquid Biopsy' Might Spot Early-Stage CancersApril 17th, 2023
- 'Alarming' Rise in Colon Cancer Rates Among Younger PeopleMarch 1st, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: